On 29 October 2026, 167 participants from more than 100 institutions in 29 countries joined the third open webinar on the Network Activities of the European Network of Comprehensive Cancer Centres (EUnetCCC). The eight Network Activities shared their results so far and invited new centres to take part.

One message came through in every presentation: after two years of mapping needs and building working groups, the Network Activities are now moving towards implementation in the cancer centres themselves.
“Many of the challenges cancer centres face, such as bringing more clinical trials to Europe, cannot be solved by one Network Activity or one centre alone,” said Live Fagereng, deputy lead of the European Cancer Collaboration Unit at Oslo University Hospital, who chaired the session. “By working across the Network Activities, the CCCs can share know-how, harmonise their approaches and learn from each other.”
Guidelines. A Europe-wide mapping found that cancer guidelines are widely used but unevenly implemented, and that adherence is rarely monitored. Claes Jönsson (Sahlgrenska CCC, Sweden) presented the plan for a “Guideline for Guidelines” for CCCs, including quality indicators. The Guidelines task works to coordinate efforts with certification, capacity building, governance and the CCCN within EUnetCCC. One example is testing pan-tumour indicators in pilots on pancreatic and colorectal cancer. Cooperation with medical societies and patient organisations is important to the Guidelines Network Activity. A collaboration proposal has gone to ESMO and a meeting has been held with European Cancer League. The first exchange visits, organised as “CCC mini-conferences”, took place in Brno and Hamburg this autumn.
Prevention. Delia Nicoară (IOCN, Romania) introduced the Cancer Prevention Hub. Relatives and caregivers who accompany patients to a cancer centre are offered prevention based on their individual risks, organised in three layers: universal prevention, risk evaluation and personalised prevention. The model was presented at IARC in Lyon in May 2026. A scoping review of hospital-based prevention pathways in Europe and a review of prevention for caregivers are building the evidence base.
Cancer Research. A survey of 33 institutions in 21 countries shaped working groups on biobanking, research twinning, patient involvement and treatment de-escalation. Ieva Ailte (OUS CCC, Norway) reported that the new De-escalation Network already has almost 80 members. It grew out of the De-escalation Symposium at the Netherlands Cancer Institute in March 2026, which gathered 111 participants from 23 countries together with EMA. The Research Twinnings call received 66 applications from 18 countries, far more than expected.
Precision Diagnostics. Divya Tallapragada (OUS CCC, Norway) described how this Network Activity supports better patient access to tailored treatment through precision diagnostics. The Molecular Tumour Board (MTB) Summit hosted in Rome (September 2026) brought together 173 participants to discuss common challenges faced by centres in running MTBs, and how these can be addressed under the umbrella of the European network of CCCs. Its minimal dataset for MTB operations was drafted in Oslo (June 2026) by 50 experts, including oncologists, pathologists, molecular biologists, HTA bodies, patients, and industry. It now underpins use cases in JA PCM, CANDLE and JA eCAN Plus and will inform guidance for CCC certification auditors. From this Network Activity, a new liquid biopsy working group is now also growing roots, with over 30 participants from 25 institutions across 14 countries joining efforts to drive the wider implementation of liquid biopsy testing.
Secondary Use of Clinical Data. Routine hospital data can do far more than support care, but only if it is captured and coded consistently, and this Network Activity is helping cancer centres get their data to that point. Divya Tallapragada (OUS CCC, Norway) presented the first pilot study of the real-world evidence (RWE) working group where 23 centres are looking at the treatment patients receive in their final months of life. Centres participate with multidisciplinary teams including clinicians, coding specialists, data engineers, biostatisticians, and CCC administrators. The group actively aligns with related initiatives such as OHDSI, FALCON, JA CancerWatch, and CANDLE. Mikael Dominguez Petrén (Karolinska CCC, Sweden) presented a Nordic-Baltic pilot that links clinicians treating children with cancer to cross-border expert case conferences.
Clinical Trials. Dina Dabaghie (Karolinska CCC, Sweden) presented the work towards a European Clinical Trials Engine. The first wave of staff exchanges between clinical trial units has already led to a joint Horizon Europe application, and the second wave of exchanges, to Luxembourg, Salamanca and Gustave Roussy, is hosted and led by the centres themselves. A first round table with industry pre-ESMO 2026 attracted more than 15 companies to discuss how we can increase Europe’s share in the clinical trial landscape together. Expert meetings have reached more than 120 research nurses, and guides on setting up an academic CRO are already used by centres building their own.
Survivorship. A mapping of 36 centres in 25 countries showed that survivorship services exist, but connected pathways rarely do. Alexandru Petrușan (IOCN, Romania) presented the Survivorship Care HUB, a navigator-led pathway from diagnosis onwards, and an open call for centres ready to implement it. The teaming in Malta in March 2026, with participants from 17 countries, produced a Patient Navigation Implementation Framework. The Brussels teaming in September focused on screening, risk stratification and personalised survivorship care, together with JANE-2.
Governance, Organisation and Leadership. Per Magnus Mæhle (OUS CCC, Norway) presented the collegial interview programme, in which 16 CCC leadership teams have visited each other in pairs. A second group starts in January 2027, and the first Leadership Forum event takes place in Lisbon on 25 November. The CCCs’ experiences have been turned into draft reference models on five topics, from developing a CCC board to managing across institutional boundaries. In June, leaders from 13 of these CCCs met in Oslo, at a two-day event co-hosted by Oslo University Hospital and BI Norwegian Business School, and launched the first governance network for CCC leaders.
The Network Activities have grown from 96 institutions in their first year to 146 today, with more than 300 active experts from 31 countries, over 60 strategic partners and more than 20 patient representatives.
Since the start in October 2024, the Network Activities have organised more than 20 face-to-face workshops, 15 webinars and 30 site visits and exchanges, as well as three European symposia and seminars in Barcelona, Amsterdam and Rome. The collaboration has also led to joint funding: an EP PerMed project, and two Horizon Europe proposals on pragmatic clinical trials and on virtual human twins in cancer research.
The next step is to make the collaboration last beyond the Joint Action as the Network Activities are becoming part of the European Network of CCCs.
In her closing remarks, Live Fagereng described how the network can be more than a place to share knowledge. It can also give CCCs a shared voice on policy and upcoming EU regulations, and be a strong partner for industry, patients and policymakers.
All the Network Activities are open to new centres. Institutions can nominate experts, join a working group, take part in exchange programmes or ask for an individual meeting to find the right Network Activity. The recording of the webinar is available on the webinar event page. To get updates every month, sign up for the WP8 newsletter.
| Date | Event | Network Activity |
|---|---|---|
| 17 Nov 2026 | Webinar with JANE-2: Towards cervical cancer elimination | Prevention |
| 24 Nov 2026 | Webinar: de-escalation in clinical practice, a case from Finland: Join on Microsoft Teams | Research |
| 25 Nov 2026 | Second EUnetCCC Community of Practice: Leadership and Governance | Governance |
| 26–27 Nov 2026 | EUnetCCC Annual Meeting, Lisbon, with sessions from several Network Activities | All |
| 8 Dec 2026 | Webinar: Improving Access for all eligible patients to Precision Diagnostics - Collaboration between CCCs and CCCNs | Precision diagnostics |
| Jan 2027 | Kick Off workshop for Collegial Interview second group | Governance |
| Jan 2027 | Open expert session on legal aspects of clinical trials | Clinical trials |
| 4 Feb 2027 | Webinar on patient involvement (World Cancer Day) | Cross-cutting |
| Q2 2027 | Technology fair for CCCs and diagnostic solution providers | Precision diagnostics |
| 3–4 March 2027 | Teaming in Denmark at Lillebaelt Hospital | Prevention |
| 18–19 March 2027 | Teaming in Luxembourg at CRCC | Survivorship |
| June 2027 | Data Summit | Secondary use of data |